1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
2 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
iSpecimen settles dispute with WestPark Capital by paying $97,500
iSpecimen reached a settlement agreement with WestPark Capital and will pay $97,500 to resolve all claims arising from prior investment banking engagements and an arbitration. WestPark had originally sought $269,999.91 plus interest and costs; the settlement is not an admission of liability. iSpecimen expects to record the payment as an expense in the quarter ended September 30, 2026. The company also reported the closing of a $2.5 million private placement with E.F. Hutton as placement agent. » More on de.investing.com
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 133.13K | 78.00% |
| Gross profit | -116.37K | 151.00% |
| Net profit | -1.19M | 34.40% |
| EBITDA | -1.02M | 95.21% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €191.67K |
Number of shares | 138.86K |
52-week high/low | €109.74 - €1.21 |
| Dividends | No |
Beta | 1.64 |
P/E ratio | -0.03 |
PEG ratio | 0.00 |
P/B ratio | 1.28 |
P/S ratio | 0.48 |
Company profile
| Name | iSpecimen Inc |
| CEO | Katharyn Field |
| Employees | 7 |
Discover assets
Shareholders of iSpecimen Inc also invest in the following assets





